Stay updated on Gene Transfer for SMA Type 1 Clinical Trial
Sign up to get notified when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.

Latest updates to the Gene Transfer for SMA Type 1 Clinical Trial page
- Check5 days agoChange DetectedThe page now includes an additional referenced publication related to onasemnogene abeparvovec in spinal muscular atrophy type 1. The page revision/version label has also been updated from the previous revision number.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded a new bibliographic entry for the Day et al. paper on Onasemnogene Abeparvovec Therapy, including an Erratum, with revision noted as v3.5.2. Removed the older version of the same reference (revision v3.5.0).SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Nationwide Children’s Hospital; removed The Research Institute at Nationwide Children’s Hospital.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding notice and the older Revision: v3.4.1 entry.SummaryDifference0.4%

Stay in the know with updates to Gene Transfer for SMA Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.